Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Epidemiology and Population Health

Genetically predicted visceral adipose tissue and risk of nine non-tumour gastrointestinal diseases: evidence from a Mendelian randomization study

International Journal of Obesity volume 47, pages 406–412 (2023)Cite this article

Subjects

Abstract

Background

Numerous studies have linked visceral adipose tissue (VAT) to gastrointestinal diseases. However, it remains unclear whether these associations reflect causal relationships.

Methods

We used a two-sample Mendelian randomization (MR) approach to elucidate the causal effect of VAT on nine non-tumour gastrointestinal diseases. The inverse-variance weighted method was used to perform the MR analyses. Complementary and multivariable MR analyses were performed to confirm the results.

Results

Genetically predicted higher VAT was associated with an increased risk of gastro-oesophageal reflux disease (GORD) (odds ratio [OR], 1.21; 95% confidence interval [CI], 1.09–1.34; P = 3.06 × 10−4), duodenal ulcer (DU) (OR, 1.40; 95% CI, 1.10–1.77; P = 0.005), cholelithiasis (OR, 1.75; 95% CI, 1.53–2.00; P = 1.14 × 10−16), and non-alcoholic fatty liver disease (NAFLD) (OR, 2.68; 95% CI, 1.87–3.82; P = 6.26 × 10−8). There were suggestive associations between VAT and gastric ulcer (GU) (OR, 1.22; 95% CI, 1.01–1.48; P = 0.035) and acute pancreatitis (AP) (OR, 1.26; 95% CI, 1.05–1.52; P = 0.013). However, there was little evidence to support the associations between VAT and inflammatory bowel disease, irritable bowel syndrome, or chronic pancreatitis. The associations with GORD, GU, and NAFLD remained in the multivariable MR analyses with adjustment for body mass index (BMI).

Conclusions

This study provided evidence in support of causal associations between VAT and GORD, GU, DU, cholelithiasis, AP, and NAFLD. Moreover, the associations between GORD, GU, and NAFLD were independent of the effect of BMI.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Schematic representation of the study design and main results of this Mendelian randomization (MR) study of the associations between visceral adipose tissue and nine non-tumour gastrointestinal diseases.
Fig. 2: Mendelian randomization associations of visceral adipose tissue with nine non-tumour gastrointestinal diseases.
Fig. 3: Multivariable Mendelian randomization associations of visceral adipose tissue with nine non-tumour gastrointestinal diseases adjusting for body mass index.

Similar content being viewed by others

Data availability

The data used in this study were publicly available and can be accessed via the links described in the supplementary material. The R-code used for this study is available from the corresponding author on reasonable request.

References

  1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390:2627–42.

  2. Camilleri M, Malhi H, Acosta A. Gastrointestinal complications of obesity. Gastroenterology. 2017;152:1656–70.

    Article  PubMed  Google Scholar 

  3. Goossens GH. The metabolic phenotype in obesity: fat mass, body fat distribution, and adipose tissue function. Obes Facts. 2017;10:207–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Matsuzawa Y. Adiponectin: a key player in obesity related disorders. Curr Pharm Des. 2010;16:1896–901.

    Article  CAS  PubMed  Google Scholar 

  5. Doyle SL, Donohoe CL, Lysaght J, Reynolds JV. Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc Nutr Soc. 2012;71:181–9.

    Article  CAS  PubMed  Google Scholar 

  6. Chung SJ, Kim D, Park MJ, Kim YS, Kim JS, Jung HC, et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut. 2008;57:1360–5.

    Article  CAS  PubMed  Google Scholar 

  7. Kim D, Chung GE, Kwak MS, Seo HB, Kang JH, Kim W, et al. Body fat distribution and risk of incident and regressed nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2016;14:132–8.e4.

    Article  PubMed  Google Scholar 

  8. Uko V, Vortia E, Achkar JP, Karakas P, Fiocchi C, Worley S, et al. Impact of abdominal visceral adipose tissue on disease outcome in pediatric Crohn’s disease. Inflamm Bowel Dis. 2014;20:2286–91.

    Article  PubMed  Google Scholar 

  9. Natu A, Stevens T, Kang L, Yasinow S, Mansoor E, Lopez R, et al. Visceral adiposity predicts severity of acute pancreatitis. Pancreas. 2017;46:776–81.

    Article  PubMed  Google Scholar 

  10. Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30:543–52.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Karlsson T, Rask-Andersen M, Pan G, Höglund J, Wadelius C, Ek WE, et al. Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease. Nat Med. 2019;25:1390–5.

    Article  CAS  PubMed  Google Scholar 

  12. Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755–64.

    Article  PubMed  Google Scholar 

  14. Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017;36:1783–802.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Bowden J, Davey, Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304–14.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–25.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hoffmann TJ, Choquet H, Yin J, Banda Y, Kvale MN, Glymour M, et al. A large multiethnic genome-wide association study of adult body mass index identifies novel loci. Genetics. 2018;210:499–515.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sanderson E, Davey Smith G, Windmeijer F, Bowden J. An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings. Int J Epidemiol. 2019;48:713–27.

    Article  PubMed  Google Scholar 

  20. Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46:1734–9.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Sanderson E, Spiller W, Bowden J. Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization. Stat Med. 2021;40:5434–52.

    Article  PubMed  PubMed Central  Google Scholar 

  22. El-Serag H. Role of obesity in GORD-related disorders. Gut. 2008;57:281–4.

    Article  PubMed  Google Scholar 

  23. Nam SY, Choi IJ, Ryu KH, Park BJ, Kim HB, Nam BH. Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. Gastroenterology. 2010;139:1902–11.e2.

    Article  PubMed  Google Scholar 

  24. El-Serag HB, Hashmi A, Garcia J, Richardson P, Alsarraj A, Fitzgerald S, et al. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett’s oesophagus: a case-control study. Gut. 2014;63:220–9.

    Article  PubMed  Google Scholar 

  25. Pandolfino JE. The relationship between obesity and GERD: “big or overblown”. Am J Gastroenterol. 2008;103:1355–7.

    Article  PubMed  Google Scholar 

  26. Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130:639–49.

    Article  PubMed  Google Scholar 

  27. Boylan MR, Khalili H, Huang ES, Chan AT. Measures of adiposity are associated with increased risk of peptic ulcer. Clin Gastroenterol Hepatol. 2014;12:1688–94.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kim HJ, Yoo TW, Park DI, Park JH, Cho YK, Sohn CI, et al. Influence of overweight and obesity on upper endoscopic findings. J Gastroenterol Hepatol. 2007;22:477–81.

    Article  PubMed  Google Scholar 

  29. Tagawa N, Fujinami A, Natsume S, Mizuno S, Kato I. Relationship between adiponectin multimer levels and subtypes of cerebral infarction. PLoS One. 2022;17:e0262542.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12:720–7.

    Article  PubMed  Google Scholar 

  31. Erhayiem B, Dhingsa R, Hawkey CJ, Subramanian V. Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn’s disease. Clin Gastroenterol Hepatol. 2011;9:684–7.e1.

    Article  PubMed  Google Scholar 

  32. Van Der Sloot KW, Joshi AD, Bellavance DR, Gilpin KK, Stewart KO, Lochhead P, et al. Visceral adiposity, genetic susceptibility, and risk of complications among individuals with Crohn’s disease. Inflamm Bowel Dis. 2017;23:82–8.

    Article  PubMed  Google Scholar 

  33. Grillot J, D’Engremont C, Parmentier AL, Lakkis Z, Piton G, Cazaux D, et al. Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn’s disease. Clin Nutr. 2020;39:3024–30.

    Article  PubMed  Google Scholar 

  34. Büning C, von Kraft C, Hermsdorf M, Gentz E, Wirth EK, Valentini L, et al. Visceral adipose tissue in patients with Crohn’s disease correlates with disease activity, inflammatory markers, and outcome. Inflamm Bowel Dis. 2015;21:2590–7.

    Article  PubMed  Google Scholar 

  35. Lee CG, Lee JK, Kang YS, Shin S, Kim JH, Lim YJ, et al. Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome. Am J Gastroenterol. 2015;110:310–9.

    Article  PubMed  Google Scholar 

  36. Sekine K, Nagata N, Sakamoto K, Arai T, Shimbo T, Shinozaki M, et al. Abdominal visceral fat accumulation measured by computed tomography associated with an increased risk of gallstone disease. J Gastroenterol Hepatol. 2015;30:1325–31.

    Article  CAS  PubMed  Google Scholar 

  37. Zhang Y, Chen TW, Zhang XM, Wang YX, Chi XX, Li XH, et al. Abdominal regional fat distribution on MRI correlates with cholecystolithiasis. PLoS One. 2014;9:e109776.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem. 2006;281:26602–14.

    Article  CAS  PubMed  Google Scholar 

  39. Berr F, Mayer M, Sackmann MF, Sauerbruch T, Holl J, Paumgartner G. Pathogenic factors in early recurrence of cholesterol gallstones. Gastroenterology. 1994;106:215–24.

    Article  CAS  PubMed  Google Scholar 

  40. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Macronutrients and insulin resistance in cholesterol gallstone disease. Am J Gastroenterol. 2008;103:2932–9.

    Article  CAS  PubMed  Google Scholar 

  41. Bükülmez A, Özer Gökaslan Ç, Oflu AT. Increase in visceral adipose tissue and subcutaneous adipose tissue thickness in children with acute pancreatitis. A case-control study. Arch Pediatr. 2021;28:29–32.

    Article  PubMed  Google Scholar 

  42. Yashima Y, Isayama H, Tsujino T, Nagano R, Yamamoto K, Mizuno S, et al. A large volume of visceral adipose tissue leads to severe acute pancreatitis. J Gastroenterol. 2011;46:1213–8.

    Article  PubMed  Google Scholar 

  43. Kuan LL, Dennison AR, Garcea G. Association of visceral adipose tissue on the incidence and severity of acute pancreatitis: A systematic review. Pancreatology. 2020;20:1056–61.

    Article  PubMed  Google Scholar 

  44. Lee S, Kim KW, Lee J, Park T, Khang S, Jeong H, et al. Visceral adiposity as a risk factor for lean non-alcoholic fatty liver disease in potential living liver donors. J Gastroenterol Hepatol. 2021;36:3212–8.

    Article  PubMed  Google Scholar 

  45. Czaja MJ. Liver injury in the setting of steatosis: crosstalk between adipokine and cytokine. Hepatology. 2004;40:19–22.

    Article  PubMed  Google Scholar 

  46. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology. 2004;40:46–54.

    Article  CAS  PubMed  Google Scholar 

  47. Schooling CM, Lopez PM, Yang Z, Zhao JV, Au Yeung SL, Huang JV. Use of multivariable mendelian randomization to address biases due to competing risk before recruitment. Front Genet. 2020;11:610852.

    Article  CAS  PubMed  Google Scholar 

  48. Yu B, Sun Y, Du X, Zhang H, Chen C, Tan X. et al. Age-specific and sex-specific associations of visceral adipose tissue mass and fat-to-muscle mass ratio with risk of mortality. J Cachexia Sarcopenia Muscle. 2023;14:406–417.

    Article  PubMed  Google Scholar 

  49. Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, Targher G. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism. 2020;111s:154170.

    Article  PubMed  Google Scholar 

  50. Persson PG, Bernell O, Leijonmarck CE, Farahmand BY, Hellers G, Ahlbom A. Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology. 1996;110:1339–45.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We want to acknowledge all the participants and investigators of the GWAS involved in the present study for generously sharing the summary-level data.

Funding

This study was supported by the National Natural Science Foundation of China (No. 81873484).

Author information

Author notes

  1. These authors contributed equally: Xingang Sun, Yifan Yuan.

Authors and Affiliations

  1. Department of Cardiology and Atrial Fibrillation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, China

    Xingang Sun, Lu Chen & Liangrong Zheng

  2. Department of Gastroenterology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, Hubei, China

    Yifan Yuan & Mei Ye

  3. Hubei Clinical Centre and Key Laboratory of Intestinal and Colorectal Diseases, Zhongnan Hospital, Wuhan University, Wuhan, 430071, Hubei, China

    Yifan Yuan & Mei Ye

Authors
  1. Xingang Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yifan Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lu Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mei Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Liangrong Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analyses were performed by Xingang Sun and Yifan Yuan. The first draft of the manuscript was written by Xingang Sun, Yifan Yuan, and Lu Chen. Liangrong Zheng and Mei Ye reviewed the final manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Mei Ye or Liangrong Zheng.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval

We used summary-level data from published studies and publicly available GWAS with ethical approval obtained from their respective institutional review boards and informed consent provided by their participants.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, X., Yuan, Y., Chen, L. et al. Genetically predicted visceral adipose tissue and risk of nine non-tumour gastrointestinal diseases: evidence from a Mendelian randomization study. Int J Obes 47, 406–412 (2023). https://doi.org/10.1038/s41366-023-01279-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41366-023-01279-4

Search

Advanced search

Quick links